GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $11,955,094 | -65.5% | 55,118 | -81.7% | 0.10% | -61.5% |
| Q4 2020 | $34,693,285 | -26.6% | 300,609 | -38.1% | 0.27% | -47.8% |
| Q3 2020 | $47,276,000 | +14.9% | 485,635 | +44.9% | 0.52% | +7.8% |
| Q2 2020 | $41,134,000 | +28.8% | 335,184 | -8.1% | 0.48% | +36.6% |
| Q1 2020 | $31,938,000 | +17.7% | 364,706 | +40.5% | 0.36% | +69.0% |
| Q4 2019 | $27,136,000 | -37.5% | 259,529 | -31.2% | 0.21% | -37.7% |
| Q3 2019 | $43,402,000 | -2.3% | 377,310 | +46.4% | 0.34% | +4.0% |
| Q2 2019 | $44,428,000 | +50.7% | 257,724 | +47.4% | 0.32% | +33.3% |
| Q1 2019 | $29,480,000 | +531.5% | 174,884 | +264.9% | 0.24% | +523.1% |
| Q4 2018 | $4,668,000 | -30.6% | 47,925 | +23.1% | 0.04% | -11.4% |
| Q3 2018 | $6,728,000 | +597.2% | 38,947 | +463.1% | 0.04% | +780.0% |
| Q2 2018 | $965,000 | +184.7% | 6,917 | +147.0% | 0.01% | +66.7% |
| Q1 2017 | $339,000 | -73.0% | 2,800 | -79.6% | 0.00% | -50.0% |
| Q2 2016 | $1,255,000 | -80.3% | 13,700 | -84.5% | 0.01% | -83.8% |
| Q1 2016 | $6,364,000 | – | 88,200 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|